Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Telemedicine house calls may be comparable to in-person care for people with Parkinson’s

A small study of 20 people with Parkinson’s disease suggests that “virtual house calls” using Web-based video conferencing provide clinical benefits comparable to in-person physician office visits, while saving patients and their caregivers time and travel.

12 Mar 2013

Results from Orion Pharma’s ORM-12741 phase IIa study on AD

A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.

12 Mar 2013

Virtual house calls provide clinical benefits for patients with Parkinson's

A small study of 20 people with Parkinson's disease suggests that "virtual house calls" using Web-based video conferencing provide clinical benefits comparable to in-person physician office visits, while saving patients and their caregivers time and travel.

12 Mar 2013

Early detection of PML may help improve survival and disability levels

The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML).

11 Mar 2013

Adrenocorticotropic hormone may help treat people with multiple sclerosis

A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

11 Mar 2013

Weill Cornell receives NIMH grant to discover novel biomarkers for chronic fatigue syndrome

Weill Cornell Medical College has been awarded more than $1.9 million by the National Institute of Mental Health of the National Institutes of Health to lead an innovative research study using advanced neuroimaging and clinical evaluations of patients with chronic fatigue syndrome (CFS).

8 Mar 2013

USF, Saneron receive patent for transplantation method using umbilical cord blood cells

Researchers at Saneron CCEL Therapeutics and the University of South Florida have received a patent relating to a method for obtaining and using umbilical cord blood cells from a donor or patient to provide neural cells for transplantation aimed at repairing a variety of neurodegenerative diseases of the brain and spinal cord, such as Parkinson's disease, Huntington's disease, multiple sclerosis, Alzheimer's disease as well as brain and spinal cord injury.

7 Mar 2013

Study: Multiple sclerosis patients with cognitive problems have more brain damage

People with multiple sclerosis who have cognitive problems, or problems with memory, attention, and concentration, have more damage to areas of the brain involved in cognitive processes than people with MS who do not have cognitive problems, according to a study published in the March 6, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Mar 2013

CALHM1 protein controls sense of taste, finds study

In collaboration with other research institutions, a Feinstein Institute for Medical Research investigator discovered a new protein that controls the sense of taste. The findings are published in the March issue of Nature.

7 Mar 2013

Researchers discover how LRRK2 mutations in familial Parkinson's damage brain cells

Researchers at Columbia University Medical Center (CUMC), with collaborators at the Albert Einstein College of Medicine of Yeshiva University, have discovered how the most common genetic mutations in familial Parkinson's disease damage brain cells.

6 Mar 2013

New NIH collaborative initiative aims to accelerate search for biomarkers in Parkinson's

Last month, the National Institutes of Health announced a new collaborative initiative that aims to accelerate the search for biomarkers -- changes in the body that can be used to predict, diagnose or monitor a disease -- in Parkinson's disease, in part by improving collaboration among researchers and helping patients get involved in clinical studies.

6 Mar 2013

Continuous dyskinesia monitoring technology for Parkinson’s to be developed by Great Lakes NeuroTechnologies

Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease.

5 Mar 2013

Phase III success with extended-release carbidopa–levodopa formulation

An extended-release formulation of carbidopa–levodopa reduces the amount of off-time in patients with Parkinson’s disease, show results from a phase III randomized trial.

5 Mar 2013

Scientists discover how to detect abnormal brain rhythms associated with Parkinson's

A team of scientists and clinicians at UC San Francisco has discovered how to detect abnormal brain rhythms associated with Parkinson's by implanting electrodes within the brains of people with the disease.

5 Mar 2013

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.

4 Mar 2013

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad.

4 Mar 2013

Researchers discover how LRRK2 mutations in familial Parkinson's damage brain cells

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the most common genetic mutations in familial Parkinson's disease damage brain cells.

4 Mar 2013

Oxford researcher wins 2013 John Dystel Prize from AAN, National Multiple Sclerosis Society

The American Academy of Neurology and the National Multiple Sclerosis Society are awarding the 2013 John Dystel Prize for MS Research to George C. Ebers, MD, a leading researcher with the University of Oxford and Oxford University Hospitals Trust in Oxford, United Kingdom.

2 Mar 2013

Researchers identify novel signaling pathway responsible for neuroprotective activity of parkin

Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich identify a novel signal transduction pathway, which activates the parkin gene and prevents stress-induced neuronal cell death.

2 Mar 2013

AAN to award 2013 Michael S. Pessin Stroke Leadership Prize to Amytis Towfighi

The American Academy of Neurology is awarding the 2013 Michael S. Pessin Stroke Leadership Prize to Amytis Towfighi, MD, with the University of Southern California and Rancho Los Amigos National Rehabilitation Center for her research in post-stroke preventive care.

2 Mar 2013

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Telemedicine house calls may be comparable to in-person care for people with Parkinson’s

Results from Orion Pharma’s ORM-12741 phase IIa study on AD

Virtual house calls provide clinical benefits for patients with Parkinson's

Early detection of PML may help improve survival and disability levels

Adrenocorticotropic hormone may help treat people with multiple sclerosis

Weill Cornell receives NIMH grant to discover novel biomarkers for chronic fatigue syndrome

USF, Saneron receive patent for transplantation method using umbilical cord blood cells

Study: Multiple sclerosis patients with cognitive problems have more brain damage

CALHM1 protein controls sense of taste, finds study

Researchers discover how LRRK2 mutations in familial Parkinson's damage brain cells

New NIH collaborative initiative aims to accelerate search for biomarkers in Parkinson's

Continuous dyskinesia monitoring technology for Parkinson’s to be developed by Great Lakes NeuroTechnologies

Phase III success with extended-release carbidopa–levodopa formulation

Scientists discover how to detect abnormal brain rhythms associated with Parkinson's

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

Researchers discover how LRRK2 mutations in familial Parkinson's damage brain cells

Oxford researcher wins 2013 John Dystel Prize from AAN, National Multiple Sclerosis Society

Researchers identify novel signaling pathway responsible for neuroprotective activity of parkin

AAN to award 2013 Michael S. Pessin Stroke Leadership Prize to Amytis Towfighi

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in